Koninklijke Philips Operating Income 2010-2023 | PHG
Koninklijke Philips annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Koninklijke Philips operating income for the quarter ending September 30, 2023 was $0.243B, a 136.99% increase year-over-year.
- Koninklijke Philips operating income for the twelve months ending September 30, 2023 was $-0.129B, a 111.73% decline year-over-year.
- Koninklijke Philips annual operating income for 2023 was $-0.124B, a 92.27% decline from 2022.
- Koninklijke Philips annual operating income for 2022 was $-1.61B, a 346.07% decline from 2021.
- Koninklijke Philips annual operating income for 2021 was $0.654B, a 62.86% decline from 2020.
| Koninklijke Philips Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-124 |
| 2022 | $-1,610 |
| 2021 | $654 |
| 2020 | $1,761 |
| 2019 | $1,842 |
| 2018 | $2,029 |
| 2017 | $1,715 |
| 2016 | $2,083 |
| 2015 | $1,102 |
| 2014 | $646 |
| 2013 | $2,645 |
| 2012 | $1,325 |
| 2011 | $1,443 |
| 2010 | $2,641 |
| 2009 | $774 |
| Koninklijke Philips Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-09-30 | $243 |
| 2023-06-30 | $242 |
| 2023-03-31 | $-626 |
| 2022-06-30 | $12 |
| 2021-06-30 | $102 |
| 2020-06-30 | $252 |
| 2019-06-30 | $392 |
| 2018-06-30 | $355 |
| 2017-06-30 | $278 |
| 2016-12-31 | $902 |
| 2016-09-30 | $537 |
| 2016-06-30 | $425 |
| 2016-03-31 | $220 |
| 2015-12-31 | $178 |
| 2015-09-30 | $381 |
| 2015-06-30 | $386 |
| 2015-03-31 | $157 |
| 2014-12-31 | $2 |
| 2014-09-30 | $-121 |
| 2014-06-30 | $455 |
| 2014-03-31 | $310 |
| 2013-12-31 | $962 |
| 2013-09-30 | $615 |
| 2013-06-30 | $665 |
| 2013-03-31 | $403 |
| 2012-12-31 | $95 |
| 2012-09-30 | $745 |
| 2012-06-30 | $206 |
| 2012-03-31 | $586 |
| 2011-12-31 | $-38 |
| 2011-09-30 | $200 |
| 2011-06-30 | $334 |
| 2011-03-31 | $831 |
| 2010-12-31 | $986 |
| 2010-09-30 | $632 |
| 2010-06-30 | $516 |
| 2010-03-31 | $525 |
| 2009-12-31 | $2,266 |
| 2009-09-30 | $407 |
| 2009-06-30 | $-1,070 |
| 2009-03-31 | $-254 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.145B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.557B | 23.90 |
| Stryker (SYK) | United States | $125.439B | 30.04 |
| Medtronic (MDT) | Ireland | $108.284B | 15.33 |
| Boston Scientific (BSX) | United States | $106.687B | 33.98 |
| EssilorLuxottica (ESLOY) | France | $99.794B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.125B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.397B | 27.30 |
| ResMed (RMD) | United States | $31.274B | 29.36 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.862B | 15.88 |
| Terumo (TRUMY) | Japan | $24.701B | 34.88 |
| Baxter (BAX) | United States | $18.217B | 12.95 |
| Insulet (PODD) | United States | $12.294B | 64.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.929B | 0.00 |
| Demant (WILYY) | Denmark | $10.100B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.650B | 25.02 |
| BellRing Brands (BRBR) | United States | $7.607B | 35.63 |
| Lantheus Holdings (LNTH) | United States | $5.164B | 12.87 |
| Haemonetics (HAE) | United States | $4.736B | 24.22 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.241B | 12.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.468B | 16.40 |
| Envista Holdings (NVST) | United States | $3.236B | 13.35 |
| QuidelOrtho (QDEL) | United States | $2.854B | 15.87 |
| TG Therapeutics (TGTX) | United States | $2.646B | 74.43 |
| Neogen (NEOG) | United States | $2.610B | 25.10 |
| Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
| ICU Medical (ICUI) | United States | $2.451B | 21.63 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.843B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
| InMode (INMD) | Israel | $1.537B | 8.17 |
| Owens & Minor (OMI) | United States | $1.386B | 12.08 |
| AdaptHealth (AHCO) | United States | $1.288B | 9.59 |
| Warby Parker (WRBY) | United States | $1.233B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.167B | 37.25 |
| AtriCure (ATRC) | United States | $0.985B | 0.00 |
| MacroGenics (MGNX) | United States | $0.917B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.915B | 0.00 |
| Evolus (EOLS) | United States | $0.830B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.813B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.710B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.696B | 14.81 |
| VAREX IMAGING (VREX) | United States | $0.644B | 15.14 |
| Quanterix (QTRX) | United States | $0.631B | 0.00 |
| PetIQ (PETQ) | United States | $0.519B | 16.97 |
| Valneva SE (VALN) | France | $0.504B | 0.00 |
| Jin Medical (ZJYL) | China | $0.494B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| Biote (BTMD) | United States | $0.452B | 8.67 |
| Surmodics (SRDX) | United States | $0.450B | 28.20 |
| ZimVie (ZIMV) | United States | $0.419B | 35.77 |
| OraSure Technologies (OSUR) | United States | $0.406B | 12.64 |
| Aurora Cannabis (ACB) | Canada | $0.350B | 0.00 |
| Cerus (CERS) | United States | $0.348B | 0.00 |
| Zynex (ZYXI) | United States | $0.341B | 46.65 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 27.96 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.248B | 15.33 |
| Veru (VERU) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.185B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.173B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.169B | 0.00 |
| InterCure (INCR) | Israel | $0.151B | 25.54 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 70.42 |
| Jushi Holdings (JUSHF) | United States | $0.137B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 22.00 |
| Cellectar Biosciences (CLRB) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.54 |
| MariMed (MRMD) | United States | $0.109B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Brainsway (BWAY) | Israel | $0.095B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.42 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.73 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |